KOZARICH JOHN W
Insider CIK 1223000 · RTRX Director · CORI Director · NTEC Director · QLTI Director · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-06-05 | 2026-06-09 | 2,938 | — | $0 | 2,938 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-06-05 | 2026-06-09 | 836 | — | $0 | 42,622 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-05-13 | 2026-05-14 | 1,575 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-13 | 2026-05-14 | 1,575 | $223.50 | $352.0K | 41,786 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-05-13 | 2026-05-14 | 1,575 | $69.51 | $109.5K | 43,361 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-05-12 | 2026-05-14 | 459 | — | $0 | 1,575 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-12 | 2026-05-14 | 459 | $224.00 | $102.8K | 41,786 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-05-12 | 2026-05-14 | 459 | $69.51 | $31.9K | 42,245 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-14 | 80 | $227.37 | $18.2K | 42,173 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-14 | 116 | $234.09 | $27.2K | 41,786 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-14 | 105 | $232.57 | $24.4K | 41,902 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-14 | 165 | $231.87 | $38.3K | 42,007 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-14 | 1 | $229.87 | $230 | 42,172 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 159 | $204.26 | $32.5K | 42,253 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 146 | $199.97 | $29.2K | 42,574 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 40 | $201.24 | $8.0K | 42,534 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 79 | $202.42 | $16.0K | 42,455 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 43 | $202.91 | $8.7K | 42,412 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 41 | $200.40 | $8.2K | 42,895 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 47 | $197.14 | $9.3K | 43,140 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 204 | $199.69 | $40.7K | 42,936 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 83 | $201.65 | $16.7K | 42,812 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 50 | $202.54 | $10.1K | 42,762 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-02 | 2026-03-04 | 42 | $203.57 | $8.5K | 42,720 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-02-02 | 2026-02-04 | 1 | $192.18 | $192 | 43,614 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-02-02 | 2026-02-04 | 39 | $191.00 | $7.4K | 43,615 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-02-02 | 2026-02-04 | 381 | $196.36 | $74.8K | 43,210 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-02-02 | 2026-02-04 | 23 | $197.20 | $4.5K | 43,187 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-02-02 | 2026-02-04 | 23 | $195.61 | $4.5K | 43,591 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-01-02 | 2026-01-06 | 102 | $188.96 | $19.3K | 43,907 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-01-02 | 2026-01-06 | 91 | $187.95 | $17.1K | 44,009 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-01-02 | 2026-01-06 | 46 | $192.40 | $8.9K | 43,654 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-01-02 | 2026-01-06 | 207 | $190.27 | $39.4K | 43,700 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-01-02 | 2026-01-06 | 21 | $186.59 | $3.9K | 44,100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 92 | $197.72 | $18.2K | 44,174 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 92 | $193.86 | $17.8K | 44,496 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 179 | $194.76 | $34.9K | 44,317 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 30 | $200.02 | $6.0K | 44,121 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 23 | $199.22 | $4.6K | 44,151 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 4 | $196.35 | $785 | 44,266 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-01 | 2025-12-03 | 47 | $195.80 | $9.2K | 44,270 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-03 | 2025-11-05 | 49 | $190.26 | $9.3K | 44,922 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-03 | 2025-11-05 | 207 | $191.25 | $39.6K | 44,715 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-03 | 2025-11-05 | 127 | $192.38 | $24.4K | 44,588 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-03 | 2025-11-05 | 84 | $189.00 | $15.9K | 44,971 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-10-01 | 2025-10-03 | 24 | $177.60 | $4.3K | 45,498 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-10-01 | 2025-10-03 | 155 | $180.01 | $27.9K | 45,147 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-10-01 | 2025-10-03 | 92 | $181.18 | $16.7K | 45,055 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-10-01 | 2025-10-03 | 196 | $178.41 | $35.0K | 45,302 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-02 | 2025-09-04 | 85 | $164.25 | $14.0K | 45,522 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-02 | 2025-09-04 | 115 | $162.52 | $18.7K | 45,607 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-02 | 2025-09-04 | 267 | $161.51 | $43.1K | 45,722 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-08-01 | 2025-08-05 | 467 | $131.88 | $61.6K | 45,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-07-10 | 2025-07-11 | 934 | $125.00 | $116.8K | 46,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-06-06 | 2025-06-10 | 5,783 | — | $0 | 5,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-06-06 | 2025-06-10 | 1,209 | — | $0 | 47,390 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-01-17 | 2025-06-02 | 2,406 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-01-17 | 2025-06-02 | 2,406 | $52.30 | $125.8K | 46,181 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-06-14 | 2024-06-18 | 5,444 | — | $0 | 5,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-06-14 | 2024-06-18 | 1,252 | — | $0 | 43,775 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-04-24 | 2024-04-26 | 2,893 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-04-24 | 2024-04-26 | 2,893 | $39.35 | $113.8K | 42,523 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-06-09 | 2023-06-13 | 5,461 | — | $0 | 5,461 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-06-09 | 2023-06-13 | 1,142 | — | $0 | 39,630 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2023-05-16 | 2023-05-18 | 4,444 | $77.20 | $343.1K | 38,488 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2023-05-08 | 2023-05-10 | 6,408 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2023-05-08 | 2023-05-10 | 5,819 | $76.51 | $445.2K | 42,802 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2023-05-08 | 2023-05-10 | 589 | $77.10 | $45.4K | 42,213 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2023-05-08 | 2023-05-10 | 6,408 | $18.82 | $120.6K | 48,621 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 6,623 | — | $0 | 6,623 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 42,213 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2022-02-28 | 2022-03-01 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-02-28 | 2022-03-01 | 908 | $102.62 | $93.2K | 41,209 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2022-02-28 | 2022-03-01 | 7,335 | $12.53 | $91.9K | 42,117 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 34,782 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-05-11 | 2021-05-13 | 4,835 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-05-11 | 2021-05-13 | 4,835 | $10.12 | $48.9K | 34,543 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-05-11 | 2021-05-13 | 391 | $128.56 | $50.3K | 34,152 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-22 | 2021-02-23 | 2,500 | — | $0 | 4,835 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-22 | 2021-02-23 | 2,500 | $10.12 | $25.3K | 29,708 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 27,208 | SEC↗ |
| NTEC Intec Pharma Ltd. | P Buy | 2019-08-23 | 2019-08-27 | 100,000 | $0.46 | $46.0K | 151,761 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-07 | 835 | — | $0 | 26,377 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-05-14 | 2019-05-14 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-05-14 | 2019-05-14 | 2,500 | $17.88 | $44.7K | 28,042 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2019-05-14 | 2019-05-14 | 2,500 | $112.92 | $282.3K | 25,542 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 29,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-10-01 | 2018-10-02 | 2,500 | $275.04 | $687.6K | 26,142 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-07-02 | 2018-07-03 | 2,500 | $207.48 | $518.7K | 28,642 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 31,142 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 27,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-04-02 | 2018-04-03 | 2,500 | $160.43 | $401.1K | 30,649 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-01-10 | 2018-01-11 | 2,500 | $145.00 | $362.5K | 33,149 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-16 | 2017-11-17 | 5,000 | $141.71 | $708.5K | 35,649 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-26 | 2,456 | $113.50 | $278.8K | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-26 | 666 | — | $0 | 40,649 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 24,500 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-07 | 2016-09-09 | 1,000 | $115.00 | $115.0K | 39,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-09-01 | 2016-09-09 | 1,666 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-01 | 2016-09-06 | 866 | $105.82 | $91.6K | 39,517 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-01 | 2016-09-06 | 200 | $103.59 | $20.7K | 40,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-01 | 2016-09-06 | 200 | $106.87 | $21.4K | 39,317 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-01 | 2016-09-06 | 400 | $104.66 | $41.9K | 40,383 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-09-01 | 2016-09-09 | 1,666 | $45.60 | $76.0K | 40,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-01 | 2016-08-02 | 200 | $135.78 | $27.2K | 41,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-01 | 2016-08-02 | 500 | $137.60 | $68.8K | 41,283 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-01 | 2016-08-02 | 200 | $138.31 | $27.7K | 41,083 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-01 | 2016-08-02 | 100 | $139.51 | $14.0K | 40,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-07-01 | 2016-07-05 | 800 | $121.54 | $97.2K | 42,083 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-07-01 | 2016-07-05 | 100 | $122.23 | $12.2K | 41,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-07-01 | 2016-07-05 | 100 | $119.47 | $11.9K | 42,883 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 6,400 | — | $0 | 28,400 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-06-01 | 2016-06-03 | 100 | $119.48 | $11.9K | 42,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-06-01 | 2016-06-03 | 900 | $117.19 | $105.5K | 43,083 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | $119.30 | $277.8K | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 44,333 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2016-05-20 | 2016-06-03 | 350 | — | $0 | 43,361 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 22,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-05-02 | 2016-05-03 | 800 | $121.45 | $97.2K | 43,911 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-05-02 | 2016-05-03 | 200 | $122.04 | $24.4K | 43,711 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-07 | 5,000 | $115.00 | $575.0K | 44,711 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-01-20 | 2016-01-22 | 1,666 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-01-20 | 2016-01-22 | 1,666 | $59.40 | $99.0K | 51,377 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 200 | $96.28 | $19.3K | 50,077 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 366 | $97.99 | $35.9K | 49,711 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 200 | $94.71 | $18.9K | 50,277 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 600 | $93.83 | $56.3K | 50,477 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 300 | $92.71 | $27.8K | 51,077 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.30 | $41.3K | 57,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.67 | $45.9K | 44,500 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 26,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 32,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2015-05-15 | 2015-05-18 | 500 | — | $0 | 49,711 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-27 | 2,754 | $89.75 | $247.2K | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 925 | — | $0 | 50,211 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2015-04-01 | 2015-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 4,400 | $3.62 | $15.9K | 20,500 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 900 | $3.63 | $3.3K | 14,600 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 900 | $3.62 | $3.3K | 16,100 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 900 | $3.62 | $3.3K | 22,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 600 | $3.62 | $2.2K | 21,100 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-22 | 2014-12-23 | 600 | $3.63 | $2.2K | 15,200 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-19 | 2014-12-23 | 1,700 | $3.45 | $5.9K | 13,700 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 4,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 12,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2014-12-04 | 2014-12-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-10-15 | 2014-10-15 | 2,000 | $45.68 | $91.4K | 49,286 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-10-07 | 2014-10-09 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-10-07 | 2014-10-09 | 2,500 | $8.58 | $21.4K | 47,286 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-05 | 3,312 | $67.53 | $223.7K | 3,312 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 666 | — | $0 | 44,786 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 1,151 | — | $0 | 44,120 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-11-25 | 2013-11-27 | 613 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-11-25 | 2013-11-27 | 630 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-11-25 | 2013-11-27 | 613 | $7.40 | $4.5K | 42,339 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-11-25 | 2013-11-27 | 630 | $6.82 | $4.3K | 42,969 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-11-18 | 2013-11-20 | 460 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-11-18 | 2013-11-20 | 460 | $14.86 | $6.8K | 41,726 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 7,335 | $32.30 | $236.9K | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 2,925 | — | $0 | 39,873 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 1,393 | — | $0 | 41,266 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2013-05-13 | 2013-05-14 | 10,000 | $7.97 | $79.7K | 10,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2012-12-21 | 2012-12-21 | 3,333 | $12.06 | $40.2K | 36,948 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2012-07-10 | 2012-07-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-05-31 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 3,592 | — | $0 | 33,615 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 2,925 | — | $0 | 30,023 | SEC↗ |